Dicarbonyl Stress in Diabetic Vascular Disease
Open Access
- 31 May 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 6186
Abstract
Late vascular complications play a prominent role in the diabetes-induced increase in morbidity and mortality. Diabetes mellitus is recognised as a risk factor driving atherosclerosis and cardiovascular mortality; even after the normalisation of blood glucose concentration, the event risk is amplified—an effect called “glycolytic memory”. The hallmark of this glycolytic memory and diabetic pathology are advanced glycation end products (AGEs) and reactive glucose metabolites such as methylglyoxal (MGO), a highly reactive dicarbonyl compound derived mainly from glycolysis. MGO and AGEs have an impact on vascular and organ structure and function, contributing to organ damage. As MGO is not only associated with hyperglycaemia in diabetes but also with other risk factors for diabetic vascular complications such as obesity, dyslipidaemia and hypertension, MGO is identified as a major player in the development of vascular complications in diabetes both on micro- as well as macrovascular level. In diabetes mellitus, the detoxifying system for MGO, the glyoxalase system, is diminished, accounting for the increased MGO concentration and glycotoxic load. This overview will summarise current knowledge on the effect of MGO and AGEs on vascular function.Keywords
This publication has 94 references indexed in Scilit:
- Edaravone Protected Human Brain Microvascular Endothelial Cells from Methylglyoxal-Induced Injury by Inhibiting AGEs/RAGE/Oxidative StressPLOS ONE, 2013
- Impact of GLO1 Knock Down on GLUT4 Trafficking and Glucose Uptake in L6 MyoblastsPLOS ONE, 2013
- Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathyTranslational Research, 2012
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Albuminuria and Estimated Glomerular Filtration Rate as Predictors of Diabetic End-Stage Renal Disease and DeathClinical Journal of the American Society of Nephrology, 2011
- Glycation of LDL by Methylglyoxal Increases Arterial AtherogenicityDiabetes, 2011
- Chronic Methylglyoxal Infusion by Minipump Causes Pancreatic β-Cell Dysfunction and Induces Type 2 Diabetes in Sprague-Dawley RatsDiabetes, 2011
- Diabetic retinopathyThe Lancet, 2010
- Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of MetforminDiabetes, 2010
- What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?Diabetologia, 2008